FDA product approval
approved product. Scenesse has indication-specific approval. This does not approve affiliate research preparations or other uses.
Melanocortin · compound · checked 2026-10-09
Melanotan I / Afamelanotide
Melanotan I / Afamelanotide is listed here as a compound. Alpha-melanocyte-stimulating-hormone analogue; afamelanotide targets melanocortin-1 receptors. Status was checked 2026-10-09. This card reports cited facts. It does not tell you to use Melanotan I / Afamelanotide or how much to take.
Last checked Oct 9, 2026 by PepBear. Not medical advice.
- FDA product
- approved product
- Compounding
- not established
- Research
- source limited
- Sport
- unknown
What is Melanotan I / Afamelanotide?
Other names in the library: Melanotan 1, MT1, MT-1, afamelanotide, scenesse, Melanotan I (10MG), Melanotan 1 — 10mg (Out of stock) / Premium, Melanotan 1 — 9mg / Premium. Evidence describes the named substance, not a quality certification or equivalence assessment of commercial stock. Listed sizes: 9 mg, 10 mg. A seller title is a listing. It does not prove the vial matches a paper.
Alpha-melanocyte-stimulating-hormone analogue; afamelanotide targets melanocortin-1 receptors.
Regulatory status, dated 2026-10-09
Compounding
not established. Legal compounding eligibility is not established here. Sale or a supplement label does not establish eligibility.
Research
source limited. Adults with erythropoietic protoporphyria meeting the Scenesse implant label.
Sport
unknown. Not individually verified against current sport rules. Check the exact ingredients with your sport authority.
What the cited papers actually measured
We mark the cited papers as A for Adults with erythropoietic protoporphyria meeting the Scenesse implant label. and Scenesse has indication-specific approval to increase pain-free light exposure.. The approved implant is not interchangeable with a research vial or nasal spray. Melanotan I and Melanotan II are distinct. Scenesse has indication-specific approval to increase pain-free light exposure. The approved implant is not interchangeable with a research vial or nasal spray. Melanotan I and Melanotan II are distinct. Risks on the record: The Scenesse label warns about serious hypersensitivity and pigmentary changes; commercial research-product safety is not established.
We mark the cited papers as A. That is our label for how strong those papers are. It does not say the compound works.
product-label
Scenesse has indication-specific approval to increase pain-free light exposure.
Adults with erythropoietic protoporphyria meeting the Scenesse implant label. The approved implant is not interchangeable with a research vial or nasal spray. Melanotan I and Melanotan II are distinct.
How long it lasts, how you store it, listed sizes
The catalog does not record a single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule.
Half-life on file: no single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule. Follow the label on the vial you hold. This page does not set a throw-away date after you add water.
U-100 math for listed Melanotan I / Afamelanotide sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.
| Listed vial | 1 mL liquid | 2 mL liquid | 3 mL liquid |
|---|---|---|---|
| 9 mg | 90 | 45 | 30 |
| 10 mg | 100 | 50 | 33.3 |
Risks and mix-ups already on the record
- The Scenesse label warns about serious hypersensitivity and pigmentary changes; commercial research-product safety is not established.
- No complete contraindication list is established for this exact preparation. Review pregnancy, allergies and existing conditions with a clinician.
- No complete interaction study for this exact preparation is verified. Ingredient combinations are not presumed compatible.
People using PepBear often log: Exact product identity, formulation, dated label and any clinician-directed observations. Record symptoms and changes alongside other medicines, sleep and activity; observations do not establish causation.
Sources
- Regulatory context; not efficacy evidence · checked 2026-10-09
Questions people ask
Is Melanotan I / Afamelanotide FDA-approved?
approved product. Scenesse has indication-specific approval. This does not approve affiliate research preparations or other uses.
Does PepBear pick an amount of Melanotan I / Afamelanotide?
The calculator turns numbers you type into U-100 units. Trial or label amounts stay as cited facts.
Related cards
Discuss the evidence and unresolved identity or safety questions with a licensed clinician. This entry provides no treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.